Mark Sheptoff Financial Planning’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-37
Closed -$5K 356
2020
Q2
$5K Hold
37
﹤0.01% 301
2020
Q1
$3K Hold
37
﹤0.01% 298
2019
Q4
$4K Hold
37
﹤0.01% 324
2019
Q3
$3K Buy
+37
New +$3K ﹤0.01% 326